Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms

Urology

Volumn 78, Issue 2, 2011, Pages 250-255

  Akduman, Blent ^a   Akduman, Deniz ^a   Tokgöz, Hsn ^a   Erol, Blent ^a   Trker, Turul ^a   Ayolu, Ferruh ^a   Aydn Mungan, Necmettin ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PROSTATE SPECIFIC ANTIGEN; TEICOPLANIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHRONIC PROSTATITIS; CLINICAL EVALUATION; CLINICAL PRACTICE; COLONY FORMING UNIT; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DRUG EFFICACY; DRUG SUBSTITUTION; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 80051471653     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.02.065     Document Type: Article

References (24)

1. M. Norberg, L. Holmberg, and M. Hggman Determinants of complications after multiple transrectal core biopsies of the prostate Eur Radiol 6 1996 457 461 (Pubitemid 126462804)
2. R. Tal, P.M. Livne, and D.M. Lask Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy J Urol 169 2003 1762 1765 (Pubitemid 36443491)
3. C.B. Bozeman, B.S. Carver, and J.A. Eastham Treatment of chronic prostatitis lowers serum prostate specific antigen J Urol 167 2002 1723 1726 (Pubitemid 34240711)
4. M. Aron, T.P. Rajeev, and N.P. Gupta Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study BJU Int 85 2000 682 685 (Pubitemid 30192834)
5. J. Feliciano, E. Teper, and M. Ferrandino The incidence of fluoroquinolone resistant infections after prostate biopsyare fluoroquinolones still effective prophylaxis? J Urol 179 2008 952 955
6. T. Miura, K. Tanaka, and K. Shigemura Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature Int J Urol 15 2008 457 459 (Pubitemid 351623884)
7. J.P. Horcajada, J. Vila, and A. Moreno-Martínez Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis J Antimicrob Chemother 49 2002 55 59 (Pubitemid 34100647)
8. M.M. Levy, M.P. Fink, and J.C. Marshall SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 31 2003 1250 1256 (Pubitemid 36444440)
9. R.B. Nadler, P.A. Humphrey, and D.S. Smith Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels J Urol 154 1995 407 413
10. J. Irani, P. Levillain, and J.M. Goujon Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value J Urol 157 1997 1301 1303 (Pubitemid 27130803)
11. O. Kaygisiz, O. Uurlu, and M. Koan Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/mL Prostate Cancer Prostatic Dis 9 2006 235 238 (Pubitemid 44317256)
12. G. Karazanashvili, and L. Managadze Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination Eur Urol 39 2001 538 543 (Pubitemid 32678968)
13. O. Ugurlu, M. Yaris, and C.V. Oztekin Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: a prospective randomized controlled trial Urol Int 84 2010 185 190
14. I.M. Thompson, D.P. Ankerst, and C. Chi Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower JAMA 294 2005 66 70 (Pubitemid 41002840)
15. S. Loeb, S.N. Gashti, and W.J. Catalona Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA) Urol Oncol 27 2009 64 66
16. E. Ozden, Y. Bostanci, and K.Y. Yakupoglu Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy Urology 74 2009 119 123
17. Z.K. Otrock, G.O. Oghlakian, and M.M. Salamoun Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon Infect Control Hosp Epidemiol 25 2004 873 877 (Pubitemid 40036766)
18. D. Lange, C. Zappavigna, and R. Hamidizadeh Bacterial sepsis after prostate biopsya new perspective Urology 74 2009 1200 1205
19. J. Carratala, A. Fernandez-Sevilla, and F. Tubau Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis Antimicrob Agents Chemother 40 1996 503 505 (Pubitemid 26049371)
20. C. Dupeyron, N. Mangeney, and L. Sedrati Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis Antimicrob Agents Chemother 38 1994 340 344 (Pubitemid 24054258)
21. M. Novella, R. Sol, and G. Soriano Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin Hepatology 25 1997 532 536 (Pubitemid 27106428)
22. S. Perea, M. Hidalgo, and A. Arcediano Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis J Antimicrob Chemother 44 1999 117 120 (Pubitemid 29353691)
23. G.M. Cannon Jr., M.C. Smaldone, and D.L. Paterson Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis Can J Urol 14 2007 3653 3655
24. E.P. Hyle, A.D. Lipworth, and T.E. Zaoutis Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection Arch Intern Med 165 2005 1375 1380 (Pubitemid 40973420)